Global Direct-to-Consumer Testing Market Research Report 2022 - Market Size, Current Insights and Development Trends

Most of the time, genetic testing is done through healthcare providers such as physicians, nurse practitioners, and genetic counselors. Healthcare providers determine which test is needed, order the test from a laboratory, collect and send the DNA sample, interpret the test results, and share the results with the patient. Often, a health insurance company covers part or all of the cost of testing.

Direct-to-consumer genetic testing is different: these genetic tests are marketed directly to customers via television, print advertisements, or the Internet, and the tests can be bought online or in stores. Customers send the company a DNA sample and receive their results directly from a secure website or in a written report. Direct-to-consumer genetic testing provides people access to their genetic information without necessarily involving a healthcare provider or health insurance company in the process.
The Direct-to-Consumer Testing market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.

The report focuses on the Direct-to-Consumer Testing market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Direct-to-Consumer Testing market.

Major Players in the Direct-to-Consumer Testing market are:
Navigenics
Gene by Gene
Helix
Siemens
MD Revolution
Genetrainer
WeGene
SERION Immunologics
Myriad Genetics
Laboratory Corporation of America
Pathway Genomics
MapMyGenome
ELITechGroup
23andMe
Tianjin Bio-Enoche Engineering Co., Ltd.
Quest Diagnostics
African Ancestry
Color Genomics
Genecodebook Oy
Thermo Fisher

On the basis of types, the Direct-to-Consumer Testing market is primarily split into:
Routine Clinical Laboratory Testing
Medical Genetic Laboratory Testing

On the basis of applications, the market covers:
Doctor Office
Internet
Others

Major Region

s or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:


Historical Years:

2017-2021

Base Year:

2021

Estimated Year:

2022

Forecast Period:

2022-2029

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
Maia-20954630

19-May-2022

105
License